EMA Issues Guidance On Medical Devices That Are Integral To Pharma Products
The Medical Devices Regulation (MDR) is the vehicle to clarify the role of EU notified bodies in medicinal products with integral medical devices, such as pre-filled syringes. Now, guidance from the EMA on the MDR shows how the pharma and device sectors are working increasingly collaboratively.
You may also be interested in...
EU regulators are being urged to get their skates on and publish guidance on new clinical requirements that will kick in soon for integral drug-device combination products.
New EU guidance includes more information for drug-device combination product makers who are worried about how to comply with requirements being introduced for pharmaceuticals under the new EU medical device rules.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.